P. D.-L. v. HHS - Tdap, panuveitis, uveitis, and vasculitis (2016)

Filed 2016-03-04Decided 2016-03-10Vaccine Tdap
compensated$50,000

Case summary [AI summaries can sometimes make mistakes]

On March 4, 2016, P. D.-L. filed a petition alleging that she suffered from panuveitis, uveitis, and vasculitis as a result of receiving a diphtheria-tetanus-acellular pertussis (Tdap) vaccine on January 20, 2012.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused these conditions. The parties reached a stipulation to settle the case, which the Special Master adopted.

As a result, P. D.-L. was awarded $50,000.00 in compensation for all damages.

The decision was issued by Special Master Laura D. Millman on March 10, 2016.

The public decision does not describe the petitioner's counsel, respondent's counsel, the specific onset of symptoms, medical history, diagnostic tests, treatments, or any expert witnesses. The decision was reissued and redacted on March 10, 2016.

Theory of causation

Petitioner P. D.-L. alleged that a Tdap vaccine administered on January 20, 2012, caused her to develop panuveitis, uveitis, and vasculitis. Respondent denied causation. The parties reached a stipulation to settle the case, and Special Master Laura D. Millman adopted the stipulation, awarding $50,000.00 in compensation. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused the injury. The case was resolved via stipulation, not through litigation of entitlement.

Source PDFs 2 total · 1 downloaded